.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Atherosclerosis remains a leading cause of cardiovascular mortality globally, with a significant impact on the Indian population. Recent advancements in multi-omics integration have pinpointed four critical atherosclerosis biomarkers—ANXA2, DBN1, ZNF385D, and IL6ST. These genes appear to bridge the gap between endothelial cell dysfunction and the dysregulation of the immune microenvironment. By understanding these molecular links, clinicians may soon have more precise tools for early diagnosis and targeted intervention.
The research utilized a single-cell atlas of atherosclerosis and high-dimensional gene co-expression networks to isolate these hub genes. Scientists narrowed their search from sixty-six endothelial-associated genes to these four core features using sophisticated machine learning models. Furthermore, the analysis revealed that these specific genes correlate strongly with the infiltration of T cells, B cells, and macrophages within atherosclerotic plaques. Consequently, these findings suggest that the local immune response is heavily influenced by endothelial gene expression.
Understanding the role of these atherosclerosis biomarkers provides a clearer picture of plaque progression. Immune infiltration analysis showed a global increase in activated immune cells in lesions, confirming that inflammation drives the disease. Specifically, the study highlighted the binding potential of these biomarkers with existing and natural therapeutic agents. Molecular docking simulations revealed that ANXA2 binds effectively with thalidomide, while IL6ST shows a high affinity for resveratrol.
Moreover, these findings offer a roadmap for future drug development and personalized medicine. Resveratrol, a compound frequently discussed for its cardioprotective benefits, exhibited a strong binding energy of -7.4 kcal/mol with the IL6ST protein. This suggests that targeting these biomarkers could mitigate the inflammatory cascade that leads to severe cardiovascular events. Doctors can now look forward to diagnostic panels that incorporate these markers for better risk stratification.
The study identified ANXA2, DBN1, ZNF385D, and IL6ST as core feature genes that link endothelial cell dysfunction to immune microenvironment changes in atherosclerosis.
These biomarkers correlate significantly with the infiltration of activated T cells, B cells, and macrophages in atherosclerotic lesions, indicating they play a role in local inflammatory dysregulation.
Yes, molecular docking suggests that ANXA2 and IL6ST can bind with thalidomide and resveratrol, respectively, potentially offering new avenues for targeted anti-inflammatory therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers have identified four core biomarkers—ANXA2, DBN1, ZNF385D, and IL6ST—that link atherosclerosis progression to immune system dysregulation....
7 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
